US Bancorp’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,534
Closed -$94K 4353
2022
Q3
$94K Sell
4,534
-174
-4% -$3.62K ﹤0.01% 2225
2022
Q2
$98K Buy
4,708
+2,057
+78% +$36.6K ﹤0.01% 2250
2022
Q1
$45K Buy
2,651
+71
+3% +$1.24K ﹤0.01% 2687
2021
Q4
$52K Buy
2,580
+105
+4% +$1.98K ﹤0.01% 2634
2021
Q3
$44K Buy
2,475
+68
+3% +$1.56K ﹤0.01% 2714
2021
Q2
$65K Sell
2,407
-29
-1% -$811 ﹤0.01% 2538
2021
Q1
$73K Sell
2,436
-99
-4% -$3.38K ﹤0.01% 2427
2020
Q4
$73K Sell
2,535
-840
-25% -$22.7K ﹤0.01% 2361
2020
Q3
$82K Sell
3,375
-367
-10% -$7.91K ﹤0.01% 2181
2020
Q2
$67K Sell
3,742
-1,004
-21% -$13.2K ﹤0.01% 2306
2020
Q1
$39K Buy
4,746
+486
+11% +$5.55K ﹤0.01% 2470
2019
Q4
$56K Sell
4,260
-6,865
-62% -$83.1K ﹤0.01% 2425
2019
Q3
$132K Sell
11,125
-9,064
-45% -$168K ﹤0.01% 2014
2019
Q2
$494K Sell
20,189
-5,493
-21% -$158K ﹤0.01% 1408
2019
Q1
$818K Buy
+25,682
New +$912K ﹤0.01% 1167

Other funds holding CVET

US Bancorp's CVET Position: Q4 2022 in Review

US Bancorp sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 4,534 shares — an estimated $94K sold.

US Bancorp first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $818K in Q1 2019. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • US Bancorp reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • US Bancorp sold 4,534 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $94K.
  • US Bancorp first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • US Bancorp's Covetrus, Inc. Common Stock position peaked at $818K in Q1 2019.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on US Bancorp's 13F filing for Q4 2022, filed 13 Feb 2023.